Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$270,348
+$56,583 QoQ
Shares Held
20,011
+16.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Laird Norton Wetherby Trust Company, LLC holds $9,717,807 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
272,486 | $3,773,930 | |
| 2 | ZTS |
Zoetis Inc.
|
13,063 | $1,544,177 | |
| 3 | HLN |
Haleon plc
|
146,703 | $1,468,496 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
52,189 | $966,539 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,003 | $594,757 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
3,347 | $440,933 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,061 | $423,516 | |
| 8 | VTRS |
Viatris Inc
This page
|
20,011 | $270,348 |
All Filings in VTRS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $270,348 | 20,011 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $213,765 | 17,170 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||